Login

Switch On Your HIV Smarts.

Quad Pill Nearing Approval?

Quad Pill Nearing Approval?

, by San Francisco AIDS Foundation

The Quad pill, an experimental once-daily, single-pill HIV regimen, is up for FDA review next week. Read on to learn more about this new treatment option—and its price tag. Read More

Updates on Women and HIV Treatment

Updates on Women and HIV Treatment

, by San Francisco AIDS Foundation

Do women and men respond differently to HIV treatment? How do hormonal changes affect women’s HIV health? Two AIDS 2012 posters addressed these questions (and raised others). Read More

AIDS 2012 Recap: Testing and Linkage to Care in San Francisco

AIDS 2012 Recap: Testing and Linkage to Care in San Francisco

, by Reilly O'Neal

San Francisco—BETA’s hometown—was well represented at AIDS 2012! This recap highlights four studies on the city’s “testing and linkage to care” approach—and the health disparities they uncovered. Read More

AIDS 2012 Recap: Complera Switch Study

AIDS 2012 Recap: Complera Switch Study

, by San Francisco AIDS Foundation

Switching to the once-daily single-pill regimen Complera was safe and helped reduce heart disease risk in the SPIRIT study, reported at AIDS 2012. Read More

Managing Peripheral Neuropathy

Managing Peripheral Neuropathy

, by San Francisco AIDS Foundation

Peripheral neuropathy, a common neurological condition among people with HIV, causes pain, tingling, or numbness in the feet and lower legs. Learn how to avoid or manage this painful condition. Read More